Ansari Husam

Francis Brian A, Vera Vanessa, Kim Joshua, Basha Mahdi M, Lum Bryant, Grayson Douglas et al.

Ab-externo gel stent implantation effectively reduced intraocular pressure (34%) and medication burden (61%) in glaucoma patients, with transient hypotony (28%) as the main adverse event, expanding surgical options.

Grover Davinder S, Kahook Malik Y, Seibold Leonard K, Singh Inder Paul, Ansari Husam, Butler Michelle R et al.

A study of the novel Ahmed ClearPath glaucoma device found it safely and effectively lowered IOP and medication use in refractory glaucoma, offering a new, potentially easier-to-implant treatment option.

Kempen John H, Van Natta Mark L, Friedman David S, Altaweel Michael M, Ansari Husam, Dunn James P et al.

This study found fluocinolone implants cause substantially higher glaucoma risk than systemic therapy in uveitis patients. Careful, indefinite IOP monitoring is crucial, as some glaucoma worsened despite expert management.

Friedman David S, Holbrook Janet T, Ansari Husam, Alexander Judith, Burke Alyce, Reed Susan B et al.

This study found uveitis patients treated with FA implants had a 4x higher risk of elevated IOP and glaucoma than those on systemic therapy, highlighting the need for aggressive IOP monitoring.

Regina Meredith, Bunya Vatinee Y, Orlin Stephen E, Ansari Husam

Two patients developed rare, persistent corneal scarring and thinning after selective laser trabeculoplasty (SLT). This highlights a potential, though uncommon, risk of lasting corneal damage from SLT.

Ansari Husam, Kempen John H